Loading
Life sciences · Journal article
Asian Journal of Research in Infectious Diseases · September 17, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Journal article.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Background: Metabolic syndrome (MetS) is a cluster of interrelated cardiometabolic risk factors, including central obesity, dyslipidaemia, hypertension and hyperglycaemia, that affect an estimated 28% of adults worldwide and predispose them to type 2 diabetes and atherosclerotic cardiovascular disease. People living with HIV (PLHIV) on antiretroviral therapy (ART) are at increased risk of MetS compared with the general population, yet data from Niger remain scarce. Aim: To determine the prevalence of metabolic syndrome and describe its associated epidemiological, clinical, biological and therapeutic factors among PLHIV receiving ART and followed at the National Hospital of Niamey (HNN), Niger. Methodology: This was a descriptive, prospective, cross-sectional study conducted over a 7-month period at the day hospital of the HNN. All consenting HIV-positive adults (≥18 years; no children were included) who had received ART for at least 3 months and met the International Diabetes Federation (IDF, 2005) criteria for MetS were enrolled using exhaustive (consecutive) sampling of all eligible patients seen during the study period; no formal sample-size calculation was performed because of this exhaustive approach. Data were analysed using EpiInfo software, version 7.2.2.6. Results: Of 954 PLHIV seen during 1,380 consultations over the study period, 103 met the IDF criteria for MetS, giving a prevalence of 10.8%. Patients were predominantly female (80.6%), with a mean age of 45.5 ± 8.4 years (range: 26–65 years). Hypertension was present in 39.8%, abdominal obesity in 75.9%, and 39.8% were overweight or obese. HDL hypocholesterolaemia (58.3%), hypertriglyceridaemia (47.6%) and total hypercholesterolaemia (31.1%) were the leading lipid abnormalities. HIV-1 accounted for 99% of infections, and most patients (77.7%) were receiving a two-NRTI plus one-NNRTI regimen. Conclusion: Metabolic syndrome affects roughly one in nine PLHIV receiving ART at the HNN, with a marked female predominance and a high burden of dyslipidaemia and abdominal obesity. These findings support the systematic integration of clinical and biological metabolic screening into routine HIV care in Niger.